Skip to main content

MoneyWorks4Me

Nectar Lifesciences informs about quarterly statement on investor complaints

06 Apr 2016 Evaluate

Nectar Lifesciences has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1768.00
Dr. Reddys Labs. 1340.25
Cipla 1382.00
Lupin 1996.55
Zydus Lifesciences 1239.95
View more..